Hospital
Big Horn Hospital Association
Big Horn Hospital Association was paid $1.07M by Medicaid between Jan 2018 and Dec 2024, across 123 billing codes. Its largest line is 99283, emergency room visit (moderate) — 56% of everything it billed.
33Billing provider infoBIG HORN HOSPITAL ASSOCIATION
HARDIN, MT 59034
HARDIN, MT 59034
33aNPI1891713533assigned 07/18/2006
33bProvider typeCritical Access Hospital
28Total paid$1.07M
24GClaims178,609
24DCodes billed123
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Montana
Rank by total paid#3 of 25
Median peer was paid$185K
This provider vs. median5.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,580 | $137K | |
| 2019 | 25,308 | $162K | |
| 2020 | 25,964 | $116K | |
| 2021 | 27,856 | $144K | |
| 2022 | 32,473 | $163K | |
| 2023 | 26,581 | $162K | |
| 2024incomplete | 19,847 | $183K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 56% | 17,843 | 15,759 | $599K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 4,830 | 4,049 | $175K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 15% | 10,539 | 9,631 | $158K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.9% | 2,295 | 1,797 | $20K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.4% | 7,166 | 1,695 | $15K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 716 | 525 | $14K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 549 | 499 | $10K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,830 | 1,694 | $8K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,484 | 3,277 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,530 | 1,068 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,451 | 1,262 | $5K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 275 | 259 | $3K |
111 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,203 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 11,908 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,289 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,143 | $3K |
| 87081 | <1% | 2,547 | $2K | |
| 97161 | <1% | 544 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,946 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,086 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,221 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,062 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 753 | $1K |
| 87070 | <1% | 2,630 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,685 | $1K |
| 83605 | <1% | 3,352 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 306 | $948.74 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,555 | $882.72 |
| J3490 | Unclassified drugs | <1% | 597 | $874.01 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,304 | $857.93 |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 69 | $819.83 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,089 | $808.75 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,267 | $736.36 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,260 | $669.43 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,357 | $590.21 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,867 | $586.38 |
| 87492 | <1% | 346 | $577.46 | |
| J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units | <1% | 42 | $546.48 |
| 87634 | <1% | 103 | $540.62 | |
| 87592 | <1% | 343 | $462.65 | |
| 87077 | <1% | 2,436 | $460.62 | |
| 87186 | <1% | 2,316 | $402.30 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,583 | $387.81 |
| 80305 | <1% | 2,407 | $380.33 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,454 | $379.74 |
| 82077 | <1% | 835 | $368.83 | |
| 80074 | <1% | 471 | $358.96 | |
| 81025 | <1% | 1,346 | $354.44 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 727 | $349.93 |
| 85027 | <1% | 1,727 | $341.19 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,727 | $277.31 |
| 81015 | <1% | 2,934 | $261.92 | |
| 86140 | <1% | 1,063 | $261.53 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 461 | $249.03 |
| 80061 | Lipid panel | <1% | 1,667 | $230.45 |
| 73130 | <1% | 13 | $219.58 | |
| 76830 | Ultrasound, transvaginal | <1% | 16 | $175.15 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,075 | $172.25 |
| 84484 | <1% | 2,011 | $171.79 | |
| 83690 | <1% | 2,371 | $164.26 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 723 | $155.50 |
| 81003 | <1% | 2,598 | $149.63 | |
| 97162 | <1% | 15 | $139.67 | |
| 80050 | General health panel | <1% | 437 | $137.16 |
| 85610 | <1% | 2,791 | $135.42 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 599 | $129.14 |
| 81001 | <1% | 1,200 | $101.85 | |
| 86592 | <1% | 937 | $88.64 | |
| 87040 | <1% | 188 | $84.18 | |
| 86803 | <1% | 201 | $76.52 | |
| 82657 | <1% | 123 | $73.56 | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 192 | $67.51 |
| 87210 | <1% | 338 | $62.44 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 738 | $60.82 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 115 | $56.42 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 115 | $56.42 |
| 87807 | <1% | 30 | $48.82 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 370 | $44.43 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 307 | $43.64 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 27 | $36.98 |
| 87581 | <1% | 26 | $36.98 | |
| 87486 | <1% | 26 | $36.98 | |
| 85007 | <1% | 389 | $32.80 | |
| 82607 | <1% | 14 | $32.38 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 228 | $31.00 |
| 85730 | <1% | 307 | $30.88 | |
| 84703 | <1% | 300 | $30.65 | |
| 83735 | <1% | 1,076 | $27.36 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 204 | $26.99 |
| 82150 | <1% | 660 | $26.40 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 247 | $22.50 |
| 83540 | <1% | 25 | $20.80 | |
| 85652 | <1% | 253 | $19.74 | |
| 83550 | <1% | 12 | $14.05 | |
| 85380 | 0% | 31 | $0.00 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 58 | $0.00 |
| 86703 | 0% | 62 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 410 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 182 | $0.00 |
| G0390 | Trauma response team associated with hospital critical care service | 0% | 21 | $0.00 |
| 84439 | 0% | 56 | $0.00 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 169 | $0.00 |
| 87338 | 0% | 13 | $0.00 | |
| 82140 | 0% | 30 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 17 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 19 | $0.00 |
| 73610 | 0% | 14 | $0.00 | |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 637 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 317 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 153 | $0.00 |
| 83880 | 0% | 102 | $0.00 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 15 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 44 | $0.00 |
| H0049 | Alcohol and/or drug screening | 0% | 156 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 19 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 13 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 98 | $0.00 |
| 87147 | 0% | 16 | $0.00 | |
| 87390 | 0% | 47 | $0.00 | |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 33 | $0.00 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 0% | 13 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 16 | $0.00 |
| J2373 | Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGATRELL, KRISTI (CEO)